Resources with keywords: antibody escape
Global Virus Network Monitors SARS-CoV-2 Variant BA.3.2 (“Cicada”), Emphasizes No Cause for Alarm (NEW 6/1, Website)
CDC
GVN assessment (3 Apr 2026) concludes BA.3.2 shows antibody escape but no evidence of increased severity or aerosol-generating transmissibility beyond known Omicron characteristics. Standard clinical laboratory biosafety (BSL-2) remains appropriate for routine SARS-CoV-2 specimen processing. Facilities should continue wastewater surveillance as an early-warning tool for variant emergence that could affect HCW exposure levels.
